Clene Nanomedicine raises $42.5m for developing nanocatalysts for neurodegenerative diseases

Clene Nanomedicine, which is engaged in developing nanocatalysts for the treatment of bioenergetic failure associated with neurodegenerative diseases, has raised $42.5 million in a Series ... Read More